By using a TLR4 overexpression plasmid, we found that ruscogenin treatment potentially alleviates DSS-induced colitis in mice by inhibiting NLRP3 inflammasome activation and canonical pyroptosis, and the protective effect may be related to the suppression of the TLR4/NF-κB signaling pathway. The gene discussed is NFKB1; the disease is colitis.